Literature DB >> 26346377

Rhizopus arrhizus and Fusarium solani Concomitant Infection in an Immunocompromised Host.

João N de Almeida Júnior1,2, Karim Y Ibrahim3, Gilda M B Del Negro4, Evandro D Bezerra5, Amaro N Duarte Neto6, Marjorie V Batista7, Rinaldo F Siciliano8, Mauro C Giudice4, Adriana L Motta9, Flávia Rossi9, Ligia C Pierrotti3, Maristela P Freire3, Marcelo Bellesso5, Juliana Pereira5, Edson Abdala3,7, Gil Benard4.   

Abstract

Neutropenic patients are at risk of the development of hyalohyphomycosis and mucormycosis. Correct identification is essential for the initiation of the specific treatment, but concomitant mold infections are rarely reported. We report one unprecedented case of concomitant mucormycosis and fusariosis in a neutropenic patient with acute myeloid leukemia. The patient developed rhino-orbital infection by Rhizopus arrhizus and disseminated infection by Fusarium solani. The first culture from a sinus biopsy grew Rhizopus, which was consistent with the histopathology report of mucormycosis. A second sinus biopsy collected later during the patient's clinical deterioration was reported as hyalohyphomycosis, and the culture yielded F. solani. Due to the discordant reports, the second biopsy was reviewed and two hyphae types suggestive of both hyalohyphomycetes and mucormycetes were found. The dual mold infection was confirmed by PCR assays from paraffinized tissue sections. Increased awareness of the existence of dual mold infections in at-risk patients is necessary. PCR methods in tissue sections may increase the diagnosis of dual mold infections. In case of sequential biopsies showing discrepant results, mixed infections have to be suspected.

Entities:  

Keywords:  Fusarium solani; Neutropenia; PCR methods; Paraffin-embedded tissue section; Rhizopus arrhizus

Mesh:

Year:  2015        PMID: 26346377     DOI: 10.1007/s11046-015-9936-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  15 in total

1.  Mixed pulmonary fungal infection with Aspergillus fumigatus and Absidia corymbifera in a patient with relapsed acute myeloid leukaemia.

Authors:  Lorna A McLintock; Brenda E S Gibson; Brian L Jones
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

2.  Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient.

Authors:  Véronique Hofman; Abdelmajid Dhouibi; Catherine Butori; Bernard Padovani; Martine Gari-Toussaint; Dea Garcia-Hermoso; Michèle Baumann; Nicolas Vénissac; Gieri Cathomas; Paul Hofman
Journal:  Diagn Pathol       Date:  2010-01-08       Impact factor: 2.644

Review 3.  Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria.

Authors:  Markus Ruhnke; Renate Arnold; Petra Gastmeier
Journal:  Lancet Oncol       Date:  2014-11-24       Impact factor: 41.316

Review 4.  Histopathologic diagnosis of fungal infections in the 21st century.

Authors:  Jeannette Guarner; Mary E Brandt
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

6.  The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Massimo Offidani; Luana Fianchi; Bruno Martino; Domenico Pastore; Marco Picardi; Alessandro Bonini; Anna Chierichini; Rosa Fanci; Cecilia Caramatti; Rosangela Invernizzi; Daniele Mattei; Maria Enza Mitra; Lorella Melillo; Franco Aversa; Maria Teresa Van Lint; Paolo Falcucci; Caterina Giovanna Valentini; Corrado Girmenia; Annamaria Nosari
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

7.  Specific detection of fusarium species in blood and tissues by a PCR technique.

Authors:  F X Hue; M Huerre; M A Rouffault; C de Bievre
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

Review 8.  Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.

Authors:  C C Blyth; N M Gilroy; S D Guy; S T Chambers; E Y Cheong; T Gottlieb; S L McGuinness; K A Thursky
Journal:  Intern Med J       Date:  2014-12       Impact factor: 2.048

Review 9.  Mucormycosis--from the pathogens to the disease.

Authors:  U Binder; E Maurer; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-02-24       Impact factor: 8.067

Review 10.  Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.

Authors:  E J Bow
Journal:  Semin Hematol       Date:  2009-07       Impact factor: 3.851

View more
  3 in total

1.  The Curious Case of "Case Report" of Infections Caused by Human and Animal Fungal Pathogens: An Educational Tool, an Online Archive, or a Format in Need of Retooling.

Authors:  Jean-Philippe Bouchara; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2018-12       Impact factor: 2.574

Review 2.  Fusariosis in a Patient with Acute Myeloid Leukemia: A Case Report and Review of the Literature.

Authors:  Mario Delia; Rosa Monno; Giorgia Giannelli; Amato Antonio Stabile Ianora; Lidia Dalfino; Domenico Pastore; Carmen Capolongo; Carla Calia; Annamaria Tortorano; Giorgina Specchia
Journal:  Mycopathologia       Date:  2016-03-23       Impact factor: 2.574

3.  Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.